Deerfield Management Company »

Belite Bio shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $37M 234k 159.96

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Cogent Biosciences (COGT)
Praxis Precision Medicines I Com New (PRAX)
Centene Corporation (CNC)
Viatris (VTRS)
Revolution Medicines (RVMD)
United Therapeutics Corporation (UTHR)
Vera Therapeutics Cl A (VERA)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Celcuity (CELC)
Neurocrine Biosciences (NBIX)
Ionis Pharmaceuticals (IONS)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Inspire Med Sys (INSP)

View all positions for Deerfield Management Company

Top funds holding Belite Bio

Darwin Global Management
RA Capital Management
Rtw Investments
Eventide Asset Management
Vestal Point Capital
Point72 Asset Management
Deerfield Management Company
Marshall Wace
UBS Group
MPM Oncology Impact Management
Holocene Advisors
Western Standard
Perceptive Advisors
Goldman Sachs Group
Soleus Capital Management

View all funds holding Belite Bio